Hepatic sEH–Nrf2 Axis Regulates Osteoclastogenesis in Osteop
2026-06-16
A recent study reveals that liver-derived soluble epoxide hydrolase (sEH) drives osteoclast differentiation and bone loss by suppressing the Nrf2 antioxidant pathway, establishing a new liver-bone axis in osteoporosis. These findings position sEH inhibition as a promising strategy for modulating bone homeostasis and chronic inflammation in preclinical models.
Oscillatory mTORC1 Activity Regulates Cell Cycle and Autopha
2026-06-15
Joshi et al. reveal that mTORC1 activity dynamically oscillates throughout the cell cycle, peaking in S/G2 and reaching its lowest in mitosis and G1. These findings clarify how mTORC1 not only drives mitotic entry but also tunes cell sensitivity to autophagy, advancing our mechanistic understanding of cell cycle regulation.
ATF6 Regulates Endothelial Inflammation Post-Hepatectomy via
2026-06-15
This study reveals that ATF6 activation mitigates endothelial inflammation after extended hepatectomy by repressing TRIM10/NF-κB signaling. These findings clarify mechanisms of post-surgical liver injury and highlight endoplasmic reticulum stress pathways as potential intervention targets.
Cell Counting Kit-8 Plus: Precision in Sensitive Cell Viabil
2026-06-14
Explore how Cell Counting Kit-8 Plus advances tetrazolium salt assays for cell viability with unmatched sensitivity and speed. This article reveals unique scientific insights and practical applications for oncology and drug screening, offering depth beyond standard guides.
BMS-777607: Mechanistic Insights & Strategic Use in MET Path
2026-06-13
Explore how BMS-777607, a selective c-Met inhibitor, enables advanced MET signaling pathway inhibition and robust cancer metastasis modeling. This article delivers unique mechanistic depth, protocol guidance, and critical assay insights for researchers.
S-Adenosylhomocysteine: Mechanisms and Research Benchmarks
2026-06-12
S-Adenosylhomocysteine (SAH) is a key metabolic intermediate and feedback inhibitor in methylation reactions. It modulates the SAM/SAH ratio, crucial for cellular methylation potential, and is widely used in cystathionine β-synthase deficiency research and methyltransferase inhibition studies. This article delivers verifiable data, protocol guidance, and clarifies common misconceptions.
Anti Reverse Cap Analog: Boosting Synthetic mRNA Translation
2026-06-12
Harnessing Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, transforms mRNA workflows with orientation-specific capping and doubled translation efficiency. Discover actionable strategies for hiPSC differentiation, mRNA therapeutics, and robust troubleshooting—supported by landmark research and comparative insights.
I-BET-762: BET Inhibitor Workflows for Ferroptosis & Inflamm
2026-06-11
I-BET-762 delivers selective, high-affinity BET inhibition, enabling robust experimental modeling of epigenetic regulation and ferroptosis in cancer and inflammation research. This article translates cutting-edge findings and real-world troubleshooting into actionable protocols that maximize reproducibility and scientific yield.
RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti
2026-06-11
Harper et al. (2025) reveal that inhibition of RNA polymerase II (Pol II) leads to cell death via an active, regulated apoptotic pathway independent of transcriptional shutdown. Their findings challenge prevailing assumptions about passive mRNA decay and highlight new mechanistic links between nuclear Pol II integrity and mitochondrial apoptosis signaling.
Topotecan in Ovarian Cancer: Mechanisms, Efficacy, and Compa
2026-06-10
This review article examines the pharmacological innovation and clinical experience surrounding topotecan, a topoisomerase I inhibitor, as documented by Kollmannsberger et al. The study highlights topotecan's mechanism, antitumor activity, and its comparative efficacy to paclitaxel (Taxol) in ovarian cancer therapy, offering valuable insight for researchers exploring chemotherapeutic strategies and combination regimens.
Pazopanib Hydrochloride: Shaping Translational Oncology Rese
2026-06-10
This thought-leadership article explores the mechanistic foundation, experimental integration, and translational relevance of Pazopanib Hydrochloride (GW786034) as a multi-target receptor tyrosine kinase inhibitor in cancer research. We synthesize current evidence—including advanced in vitro methodologies and benchmarking strategies—with practical guidance for translational researchers, while situating APExBIO’s offering at the forefront of next-generation anti-angiogenic agent deployment.
Cisapride (R 51619): New Horizons in Cardiac Electrophysiolo
2026-06-09
Explore how Cisapride (R 51619) is transforming cardiac electrophysiology and translational safety screening. This article blends mechanistic insight, high-content experimental validation, and strategic guidance for researchers seeking to advance predictive cardiotoxicity models and de-risk drug development using APExBIO’s high-purity research tool.
Ro 3306: Optimizing CDK1 Inhibition for Cell Cycle G2/M Arre
2026-06-09
Ro 3306 delivers precise, ATP-competitive CDK1 inhibition, enabling robust G2/M cell cycle arrest and advanced study of DNA repair and cancer cell synchronization. This guide distills practical workflows, troubleshooting tactics, and new mechanistic insights from oscillatory mTORC1 research to maximize your experimental design.
Pazopanib Hydrochloride: Streamlining Cancer Research Workfl
2026-06-08
Pazopanib Hydrochloride (GW786034) redefines in vitro cancer research by targeting angiogenesis and tumor proliferation with high precision. This article delivers actionable experimental workflows, troubleshooting strategies, and protocol optimizations, empowering researchers to achieve robust and reproducible results.
Azathramycin A: Macrolide Antibiotic Workflows for TB Resear
2026-06-08
Azathramycin A enables targeted inhibition of Mycobacterium tuberculosis ribosomes, facilitating advanced resistance studies and mechanistic screens. This guide provides stepwise protocols, troubleshooting advice, and cross-reference to landmark research on macrolide resistance—empowering robust and reproducible antibacterial agent workflows.
458 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page